<SEC-DOCUMENT>0001387131-22-001918-index.html : 20220214
<SEC-HEADER>0001387131-22-001918.hdr.sgml : 20220214
<ACCEPTANCE-DATETIME>20220214163847
ACCESSION NUMBER:		0001387131-22-001918
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220214
DATE AS OF CHANGE:		20220214
GROUP MEMBERS:		BKB GROWTH INVESTMENTS, LLC
GROUP MEMBERS:		PAUL B. MANNING REVOCABLE TRUST DATED MAY 10, 2000

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Candel Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001841387
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				522214851
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93359
		FILM NUMBER:		22633340

	BUSINESS ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 450
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
		BUSINESS PHONE:		617-916-5445

	MAIL ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 450
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Candel Therapeutics, Inic.
		DATE OF NAME CHANGE:	20210120

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Manning Paul B
		CENTRAL INDEX KEY:			0001494695

	FILING VALUES:
		FORM TYPE:		SC 13D

	MAIL ADDRESS:	
		STREET 1:		200 GARRETT STREET SUITE S
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>cadl-sc13d_072921.htm
<DESCRIPTION>SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
<TEXT>
Document 1 - file: cadl-sc13d_072921.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>ex-1.htm
<DESCRIPTION>AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D.
<TEXT>
Document 2 - file: ex-1.htm

</DOCUMENT>
</SEC-DOCUMENT>